<?xml version="1.0" encoding="UTF-8" standalone="no"?><document setID="34a29fae-b549-41ed-bd7d-e98fe2110bef"><labelDrug name="PhosLo"><Normalization><mmtx cui="C0722621" preferredWord="Phoslo" semType="phsu, orch"/></Normalization></labelDrug><generic name="Calcium Acetate"/><sentence id="Dailymed.34a29fae-b549-41ed-bd7d-e98fe2110bef.s.1" text="PHOSLO (calcium acetate) capsule" type="negative"><entity charOffset="0:6" id="Dailymed.34a29fae-b549-41ed-bd7d-e98fe2110bef.s.1.e.0" text="phoslo" type="Biomedical_Entity"><Normalization><mmtx cui="C0722621" phraseText="PHOSLO" preferredWord="Phoslo" semType="phsu, orch"/><RxNorm RxCui="219236"/></Normalization></entity><entity charOffset="8:23" id="Dailymed.34a29fae-b549-41ed-bd7d-e98fe2110bef.s.1.e.1" text="calcium acetate" type="Biomedical_Entity"><Normalization><mmtx cui="C0717537" phraseText="(calcium acetate" preferredWord="calcium acetate" semType="phsu, irda, orch"/><RxNorm RxCui="1895"/></Normalization></entity><pair ddi="false" e1="Dailymed.34a29fae-b549-41ed-bd7d-e98fe2110bef.s.1.e.0" e2="Dailymed.34a29fae-b549-41ed-bd7d-e98fe2110bef.s.1.e.1"/></sentence><sentence id="Dailymed.34a29fae-b549-41ed-bd7d-e98fe2110bef.s.2" text="PhosLo acts as a phosphate binder.  " type="negative"><entity charOffset="0:6" id="Dailymed.34a29fae-b549-41ed-bd7d-e98fe2110bef.s.2.e.0" text="phoslo" type="Biomedical_Entity"><Normalization><mmtx cui="C0722621" phraseText="PhosLo" preferredWord="Phoslo" semType="phsu, orch"/><RxNorm RxCui="219236"/></Normalization></entity><entity charOffset="17:33" id="Dailymed.34a29fae-b549-41ed-bd7d-e98fe2110bef.s.2.e.1" text="phosphate binder" type="Biomedical_Entity"><Normalization><mmtx cui="C2267031" phraseText="acts as a phosphate binder." preferredWord="Phosphate Binder [EPC]" semType="phsu"/><RxNorm RxCui="8208"/></Normalization></entity><pair ddi="false" e1="Dailymed.34a29fae-b549-41ed-bd7d-e98fe2110bef.s.2.e.0" e2="Dailymed.34a29fae-b549-41ed-bd7d-e98fe2110bef.s.2.e.1"/></sentence><sentence id="Dailymed.34a29fae-b549-41ed-bd7d-e98fe2110bef.s.8" text="Patients with end stage renal disease may develop hypercalcemia when treated with calcium, including calcium acetate (PhosLo ).  " type="negative"><entity charOffset="118:124" id="Dailymed.34a29fae-b549-41ed-bd7d-e98fe2110bef.s.8.e.0" text="phoslo" type="Biomedical_Entity"><Normalization><mmtx cui="C0722621" phraseText="(PhosLo" preferredWord="Phoslo" semType="phsu, orch"/><RxNorm RxCui="219236"/></Normalization></entity><entity charOffset="82:89" id="Dailymed.34a29fae-b549-41ed-bd7d-e98fe2110bef.s.8.e.1" text="calcium" type="Biomedical_Entity"><Normalization><mmtx cui="C0006675" phraseText="treated with calcium," preferredWord="Calcium" semType="bacs, phsu, elii"/><RxNorm RxCui="1895"/></Normalization></entity><entity charOffset="101:116" id="Dailymed.34a29fae-b549-41ed-bd7d-e98fe2110bef.s.8.e.2" text="calcium acetate" type="Biomedical_Entity"><Normalization><mmtx cui="C0717537" phraseText="calcium acetate" preferredWord="calcium acetate" semType="phsu, irda, orch"/><RxNorm RxCui="1895"/></Normalization></entity><pair ddi="false" e1="Dailymed.34a29fae-b549-41ed-bd7d-e98fe2110bef.s.8.e.1" e2="Dailymed.34a29fae-b549-41ed-bd7d-e98fe2110bef.s.8.e.0"/><pair ddi="false" e1="Dailymed.34a29fae-b549-41ed-bd7d-e98fe2110bef.s.8.e.2" e2="Dailymed.34a29fae-b549-41ed-bd7d-e98fe2110bef.s.8.e.0"/><pair ddi="false" e1="Dailymed.34a29fae-b549-41ed-bd7d-e98fe2110bef.s.8.e.1" e2="Dailymed.34a29fae-b549-41ed-bd7d-e98fe2110bef.s.8.e.2"/></sentence><sentence id="Dailymed.34a29fae-b549-41ed-bd7d-e98fe2110bef.s.9" text="Avoid the use of calcium supplements, including calcium-based nonprescription antacids, concurrently with PhosLo ." type="negative"><entity charOffset="17:36" id="Dailymed.34a29fae-b549-41ed-bd7d-e98fe2110bef.s.9.e.0" text="calcium supplements" type="Biomedical_Entity"><Normalization><mmtx cui="C3540037" phraseText="the use of calcium supplements," preferredWord="CALCIUM SUPPLEMENTS" semType="phsu, vita"/><RxNorm RxCui="1895"/></Normalization></entity><entity charOffset="62:77" id="Dailymed.34a29fae-b549-41ed-bd7d-e98fe2110bef.s.9.e.1" text="nonprescription" type="Biomedical_Entity"><Normalization><mmtx cui="C0013231" phraseText="calcium-based nonprescription antacids," preferredWord="Drugs, Non-Prescription" semType="phsu"/><RxNorm RxCui="NA"/></Normalization></entity><entity charOffset="106:112" id="Dailymed.34a29fae-b549-41ed-bd7d-e98fe2110bef.s.9.e.2" text="phoslo" type="Biomedical_Entity"><Normalization><mmtx cui="C0722621" phraseText="concurrently with PhosLo ." preferredWord="Phoslo" semType="phsu, orch"/><RxNorm RxCui="219236"/></Normalization></entity><entity charOffset="48:86" id="Dailymed.34a29fae-b549-41ed-bd7d-e98fe2110bef.s.9.e.3" text="calcium-based antacids" type="Biomedical_Entity"><Normalization><mmtx cui="C0304542" phraseText="calcium-based nonprescription antacids," preferredWord="Calcium antacid" semType="inch, phsu"/><RxNorm RxCui="91254"/></Normalization></entity><pair ddi="false" e1="Dailymed.34a29fae-b549-41ed-bd7d-e98fe2110bef.s.9.e.0" e2="Dailymed.34a29fae-b549-41ed-bd7d-e98fe2110bef.s.9.e.1"/><pair ddi="false" e1="Dailymed.34a29fae-b549-41ed-bd7d-e98fe2110bef.s.9.e.0" e2="Dailymed.34a29fae-b549-41ed-bd7d-e98fe2110bef.s.9.e.2"/><pair ddi="false" e1="Dailymed.34a29fae-b549-41ed-bd7d-e98fe2110bef.s.9.e.0" e2="Dailymed.34a29fae-b549-41ed-bd7d-e98fe2110bef.s.9.e.3"/><pair ddi="false" e1="Dailymed.34a29fae-b549-41ed-bd7d-e98fe2110bef.s.9.e.1" e2="Dailymed.34a29fae-b549-41ed-bd7d-e98fe2110bef.s.9.e.2"/><pair ddi="false" e1="Dailymed.34a29fae-b549-41ed-bd7d-e98fe2110bef.s.9.e.3" e2="Dailymed.34a29fae-b549-41ed-bd7d-e98fe2110bef.s.9.e.1"/><pair ddi="false" e1="Dailymed.34a29fae-b549-41ed-bd7d-e98fe2110bef.s.9.e.3" e2="Dailymed.34a29fae-b549-41ed-bd7d-e98fe2110bef.s.9.e.2"/></sentence><sentence id="Dailymed.34a29fae-b549-41ed-bd7d-e98fe2110bef.s.23" text="Maintain the serum calcium-phosphorus (Ca x P) product below 55 mg2/dL2." type="negative"><entity charOffset="64:67" id="Dailymed.34a29fae-b549-41ed-bd7d-e98fe2110bef.s.23.e.0" text="mg2" type="Biomedical_Entity"><Normalization><mmtx cui="C2346927" phraseText="the serum calcium-phosphorus (Ca x P) product below 55 mg2/dL2." preferredWord="Magnesium Cation" semType="phsu, elii"/><RxNorm RxCui="315"/></Normalization></entity><entity charOffset="19:26" id="Dailymed.34a29fae-b549-41ed-bd7d-e98fe2110bef.s.23.e.1" text="calcium" type="Biomedical_Entity"><Normalization><mmtx cui="C2936886" phraseText="the serum calcium-phosphorus (Ca x P) product below 55 mg2/dL2." preferredWord="Calcium [EPC]" semType="phsu"/><RxNorm RxCui="1895"/></Normalization></entity><pair ddi="false" e1="Dailymed.34a29fae-b549-41ed-bd7d-e98fe2110bef.s.23.e.1" e2="Dailymed.34a29fae-b549-41ed-bd7d-e98fe2110bef.s.23.e.0"/></sentence><sentence id="Dailymed.34a29fae-b549-41ed-bd7d-e98fe2110bef.s.27" text="The drug interaction of PhosLo  is characterized by the potential of calcium to bind to drugs with anionic functions (e.g., carboxyl and hydroxyl groups).  " type="negative"><entity charOffset="69:76" id="Dailymed.34a29fae-b549-41ed-bd7d-e98fe2110bef.s.27.e.0" text="calcium" type="Biomedical_Entity"><Normalization><mmtx cui="C0006675" phraseText="characterized by the potential of calcium to" preferredWord="Calcium" semType="bacs, phsu, elii"/><RxNorm RxCui="1895"/></Normalization></entity><entity charOffset="24:30" id="Dailymed.34a29fae-b549-41ed-bd7d-e98fe2110bef.s.27.e.1" text="phoslo" type="Biomedical_Entity"><Normalization><mmtx cui="C0722621" phraseText="The drug interaction of PhosLo" preferredWord="Phoslo" semType="phsu, orch"/><RxNorm RxCui="219236"/></Normalization></entity><pair ddi="false" e1="Dailymed.34a29fae-b549-41ed-bd7d-e98fe2110bef.s.27.e.1" e2="Dailymed.34a29fae-b549-41ed-bd7d-e98fe2110bef.s.27.e.0"/></sentence><sentence biomedicalEntities="3" id="Dailymed.34a29fae-b549-41ed-bd7d-e98fe2110bef.s.28" lineNumber="33" text="PhosLo  may decrease the bioavailability of tetracyclines or fluoroquinolones via this mechanism." type="regular"><entity charOffset="0:6" id="Dailymed.34a29fae-b549-41ed-bd7d-e98fe2110bef.s.28.e.0" text="PhosLo" type="Drug"><Normalization><mmtx cui="C0722621" phraseText="PhosLo" preferredWord="Phoslo" semType="phsu, orch"/><RxNorm RxCui="219236"/></Normalization></entity><entity charOffset="44:57" id="Dailymed.34a29fae-b549-41ed-bd7d-e98fe2110bef.s.28.e.1" text="tetracyclines" type="Drug_Class"><Normalization><mmtx cui="C1744619" phraseText="the bioavailability of tetracyclines" preferredWord="Tetracycline Antibiotics" semType="orch, antb"/><RxNorm RxCui="142446"/></Normalization></entity><entity charOffset="61:77" id="Dailymed.34a29fae-b549-41ed-bd7d-e98fe2110bef.s.28.e.2" text="fluoroquinolones" type="Drug_Class"><Normalization><mmtx cui="C0949665" phraseText="fluoroquinolones via this mechanism." preferredWord="Fluoroquinolones" semType="phsu, orch"/><RxNorm RxCui="1427693"/></Normalization></entity><entity charOffset="12:40" id="Dailymed.34a29fae-b549-41ed-bd7d-e98fe2110bef.s.28.e.3" text="decrease the bioavailability" type="Decrease_Interaction"/><drugInteraction id="Dailymed.34a29fae-b549-41ed-bd7d-e98fe2110bef.s.28.ddi.1"><interaction trigger="Dailymed.34a29fae-b549-41ed-bd7d-e98fe2110bef.s.28.e.3"><relations><relation type="hasObject"><entity id="Dailymed.34a29fae-b549-41ed-bd7d-e98fe2110bef.s.28.e.1"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.34a29fae-b549-41ed-bd7d-e98fe2110bef.s.28.e.0"/></relation><relation type="hasObject"><entity id="Dailymed.34a29fae-b549-41ed-bd7d-e98fe2110bef.s.28.e.2"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.34a29fae-b549-41ed-bd7d-e98fe2110bef.s.28.e.0" e2="Dailymed.34a29fae-b549-41ed-bd7d-e98fe2110bef.s.28.e.1" trigger="Dailymed.34a29fae-b549-41ed-bd7d-e98fe2110bef.s.28.e.3" type="Decrease_Interaction"/><pair ddi="true" e1="Dailymed.34a29fae-b549-41ed-bd7d-e98fe2110bef.s.28.e.0" e2="Dailymed.34a29fae-b549-41ed-bd7d-e98fe2110bef.s.28.e.2" trigger="Dailymed.34a29fae-b549-41ed-bd7d-e98fe2110bef.s.28.e.3" type="Decrease_Interaction"/></sentence><sentence id="Dailymed.34a29fae-b549-41ed-bd7d-e98fe2110bef.s.29" text="There are no empirical data on avoiding drug interactions between calcium acetate or PhosLo  and most concomitant drugs.  " type="negative"><entity charOffset="10:27" id="Dailymed.34a29fae-b549-41ed-bd7d-e98fe2110bef.s.29.e.0" text="no data" type="Biomedical_Entity"><Normalization><mmtx cui="C1572381" phraseText="no empirical data on avoiding drug interactions" preferredWord="No Data re: Ingredient" semType="phsu"/><RxNorm RxCui="53704"/></Normalization></entity><entity charOffset="85:91" id="Dailymed.34a29fae-b549-41ed-bd7d-e98fe2110bef.s.29.e.1" text="phoslo" type="Biomedical_Entity"><Normalization><mmtx cui="C0722621" phraseText="PhosLo" preferredWord="Phoslo" semType="phsu, orch"/><RxNorm RxCui="219236"/></Normalization></entity><entity charOffset="66:81" id="Dailymed.34a29fae-b549-41ed-bd7d-e98fe2110bef.s.29.e.2" text="calcium acetate" type="Biomedical_Entity"><Normalization><mmtx cui="C0717537" phraseText="between calcium acetate" preferredWord="calcium acetate" semType="phsu, irda, orch"/><RxNorm RxCui="1895"/></Normalization></entity><pair ddi="false" e1="Dailymed.34a29fae-b549-41ed-bd7d-e98fe2110bef.s.29.e.0" e2="Dailymed.34a29fae-b549-41ed-bd7d-e98fe2110bef.s.29.e.1"/><pair ddi="false" e1="Dailymed.34a29fae-b549-41ed-bd7d-e98fe2110bef.s.29.e.0" e2="Dailymed.34a29fae-b549-41ed-bd7d-e98fe2110bef.s.29.e.2"/><pair ddi="false" e1="Dailymed.34a29fae-b549-41ed-bd7d-e98fe2110bef.s.29.e.2" e2="Dailymed.34a29fae-b549-41ed-bd7d-e98fe2110bef.s.29.e.1"/></sentence><sentence id="Dailymed.34a29fae-b549-41ed-bd7d-e98fe2110bef.s.30" text="When administering an oral medication with PhosLo  where a reduction in the bioavailability of that medication would have a clinically significant effect on its safety or efficacy, administer the drug one hour before or three hours after PhosLo  or calcium acetate.  " type="negative"><entity charOffset="249:264" id="Dailymed.34a29fae-b549-41ed-bd7d-e98fe2110bef.s.30.e.0" text="calcium acetate" type="Biomedical_Entity"><Normalization><mmtx cui="C0717537" phraseText="calcium acetate." preferredWord="calcium acetate" semType="phsu, irda, orch"/><RxNorm RxCui="1895"/></Normalization></entity><entity charOffset="238:244" id="Dailymed.34a29fae-b549-41ed-bd7d-e98fe2110bef.s.30.e.1" text="phoslo" type="Biomedical_Entity"><Normalization><mmtx cui="C0722621" phraseText="three hours after PhosLo" preferredWord="Phoslo" semType="phsu, orch"/><RxNorm RxCui="219236"/></Normalization></entity><entity charOffset="43:49" id="Dailymed.34a29fae-b549-41ed-bd7d-e98fe2110bef.s.30.e.2" text="phoslo" type="Biomedical_Entity"><Normalization><mmtx cui="C0722621" phraseText="an oral medication with PhosLo  where" preferredWord="Phoslo" semType="phsu, orch"/><RxNorm RxCui="219236"/></Normalization></entity><pair ddi="false" e1="Dailymed.34a29fae-b549-41ed-bd7d-e98fe2110bef.s.30.e.1" e2="Dailymed.34a29fae-b549-41ed-bd7d-e98fe2110bef.s.30.e.0"/><pair ddi="false" e1="Dailymed.34a29fae-b549-41ed-bd7d-e98fe2110bef.s.30.e.2" e2="Dailymed.34a29fae-b549-41ed-bd7d-e98fe2110bef.s.30.e.0"/></sentence><sentence biomedicalEntities="1" id="Dailymed.34a29fae-b549-41ed-bd7d-e98fe2110bef.s.31" lineNumber="35" text="Monitor blood levels of the concomitant drugs that have a narrow therapeutic range.  " type="irregular"><entity charOffset="0:7" id="Dailymed.34a29fae-b549-41ed-bd7d-e98fe2110bef.s.31.e.0" text="Monitor" type="Caution_Interaction"/><entity charOffset="40:82" id="Dailymed.34a29fae-b549-41ed-bd7d-e98fe2110bef.s.31.e.2" text="drugs that have a narrow therapeutic range" type="Drug_Class"><Normalization><RxNorm RxCui="NA"/></Normalization></entity><drugInteraction id="Dailymed.34a29fae-b549-41ed-bd7d-e98fe2110bef.s.31.ddi.1"><interaction trigger="Dailymed.34a29fae-b549-41ed-bd7d-e98fe2110bef.s.31.e.0"><relations><relation type="hasObject"><ellipsisSentence id="Dailymed.34a29fae-b549-41ed-bd7d-e98fe2110bef.s.30" text="When administering an oral medication with PhosLo  where a reduction in the bioavailability of that medication would have a clinically significant effect on its safety or efficacy, administer the drug one hour before or three hours after PhosLo  or calcium acetate.  "><entity charOffset="238:244" id="Dailymed.34a29fae-b549-41ed-bd7d-e98fe2110bef.s.30.e.0" text="PhosLo" type="Drug"><Normalization><mmtx cui="C0722621" phraseText="three hours after PhosLo" preferredWord="Phoslo" semType="phsu, orch"/></Normalization></entity></ellipsisSentence></relation><relation type="hasPrecipitant"><entity id="Dailymed.34a29fae-b549-41ed-bd7d-e98fe2110bef.s.31.e.2"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="labelDrug" e2="Dailymed.34a29fae-b549-41ed-bd7d-e98fe2110bef.s.31.e.2"/></sentence><sentence id="Dailymed.34a29fae-b549-41ed-bd7d-e98fe2110bef.s.32" text="Patients taking anti-arrhythmic medications for the control of arrhythmias and anti-seizure medications for the control of seizure disorders were excluded from the clinical trials with all forms of calcium acetate." type="negative"><entity charOffset="16:31" id="Dailymed.34a29fae-b549-41ed-bd7d-e98fe2110bef.s.32.e.0" text="anti-arrhythmic" type="Biomedical_Entity"><Normalization><mmtx cui="C0003195" phraseText="anti-arrhythmic medications for the control of arrhythmias" preferredWord="Anti-Arrhythmia Agents" semType="phsu"/><RxNorm RxCui="1436910"/></Normalization></entity><entity charOffset="84:103" id="Dailymed.34a29fae-b549-41ed-bd7d-e98fe2110bef.s.32.e.1" text="seizure medications" type="Biomedical_Entity"><Normalization><mmtx cui="C0748603" phraseText="anti-seizure medications for the control of seizure disorders" preferredWord="seizure medication" semType="phsu"/><RxNorm RxCui="1023130"/></Normalization></entity><entity charOffset="198:213" id="Dailymed.34a29fae-b549-41ed-bd7d-e98fe2110bef.s.32.e.2" text="calcium acetate" type="Biomedical_Entity"><Normalization><mmtx cui="C0717537" phraseText="forms of calcium acetate." preferredWord="calcium acetate" semType="phsu, irda, orch"/><RxNorm RxCui="1895"/></Normalization></entity><pair ddi="false" e1="Dailymed.34a29fae-b549-41ed-bd7d-e98fe2110bef.s.32.e.0" e2="Dailymed.34a29fae-b549-41ed-bd7d-e98fe2110bef.s.32.e.1"/><pair ddi="false" e1="Dailymed.34a29fae-b549-41ed-bd7d-e98fe2110bef.s.32.e.0" e2="Dailymed.34a29fae-b549-41ed-bd7d-e98fe2110bef.s.32.e.2"/><pair ddi="false" e1="Dailymed.34a29fae-b549-41ed-bd7d-e98fe2110bef.s.32.e.1" e2="Dailymed.34a29fae-b549-41ed-bd7d-e98fe2110bef.s.32.e.2"/></sentence><sentence biomedicalEntities="2" id="Dailymed.34a29fae-b549-41ed-bd7d-e98fe2110bef.s.34" lineNumber="39" text="In a study of 15 healthy subjects, a co-administered single dose of 4 calcium acetate tablets approximately 2.7 g, decreased the bioavailability of ciprofloxacin by approximately 50%." type="regular"><entity charOffset="70:93" id="Dailymed.34a29fae-b549-41ed-bd7d-e98fe2110bef.s.34.e.0" text="calcium acetate tablets" type="Drug"><Normalization><mmtx cui="C0717537" phraseText="single dose of 4 calcium acetate tablets approximately 2.7 g," preferredWord="calcium acetate" semType="phsu, irda, orch"/><RxNorm RxCui="1895"/></Normalization></entity><entity charOffset="148:161" id="Dailymed.34a29fae-b549-41ed-bd7d-e98fe2110bef.s.34.e.1" text="ciprofloxacin" type="Drug"><Normalization><mmtx cui="C0008809" phraseText="the bioavailability of ciprofloxacin" preferredWord="Ciprofloxacin" semType="phsu, orch"/><RxNorm RxCui="81981"/></Normalization></entity><entity charOffset="115:144" id="Dailymed.34a29fae-b549-41ed-bd7d-e98fe2110bef.s.34.e.2" text="decreased the bioavailability" type="Decrease_Interaction"/><drugInteraction id="Dailymed.34a29fae-b549-41ed-bd7d-e98fe2110bef.s.34.ddi.1"><interaction trigger="Dailymed.34a29fae-b549-41ed-bd7d-e98fe2110bef.s.34.e.2"><relations><relation type="hasPrecipitant"><entity id="Dailymed.34a29fae-b549-41ed-bd7d-e98fe2110bef.s.34.e.0"/></relation><relation type="hasObject"><entity id="Dailymed.34a29fae-b549-41ed-bd7d-e98fe2110bef.s.34.e.1"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.34a29fae-b549-41ed-bd7d-e98fe2110bef.s.34.e.0" e2="Dailymed.34a29fae-b549-41ed-bd7d-e98fe2110bef.s.34.e.1" trigger="Dailymed.34a29fae-b549-41ed-bd7d-e98fe2110bef.s.34.e.2" type="Decrease_Interaction"/></sentence><positiveExamples number="4"/><negativeExamples number="21"/></document>